These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11799757)

  • 1. [Complex effects of cavinton on climacteric symptoms].
    Kolarov G; Orbetsova M; Nalbanski B; Kamenov Z; Georgiev S; Filipov E; Petrova Iu; Marinov B; Georgiev G
    Akush Ginekol (Sofiia); 2001; 42(2):37-41. PubMed ID: 11799757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant effect of cavinton in the treatment of climacteric symptoms.
    Kiss E
    Ther Hung; 1990; 38(4):170-3. PubMed ID: 2094056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the combined hormonal replacement drug estradiol valerate/levonorgestrel on climacteric complaints, endometrium and lipid profile of peri- and postmenopausal women.
    Georgiev DB; Golbs S; Goudev A
    Methods Find Exp Clin Pharmacol; 2001 May; 23(4):197-202. PubMed ID: 11676228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possibilities for an individualized approach to the treatment of climacteric symptoms with phytoestrogens].
    Kolarov G; Nalbanski B; Kamenov Z; Orbetsova M; Georgiev S; Nikolov A; Marinov B
    Akush Ginekol (Sofiia); 2001; 40(4):18-21. PubMed ID: 11803864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low-dose estrogens in the treatment of the climacteric syndrome].
    Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
    Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
    Schram JH; Boerrigter PJ; The TY
    Maturitas; 1995 Sep; 22(2):121-30. PubMed ID: 8538480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of hormonal replacement therapy on symptoms of climacteric syndrome and selected metabolic parameters].
    Kornaga E
    Ginekol Pol; 2001 Mar; 72(3):113-20. PubMed ID: 11398578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R; Urdinola J; Onatra W; Sánchez F; Posso H
    Maturitas; 1999 May; 32(1):41-50. PubMed ID: 10423715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The atherogenic lipid profile parameters and fibrinogen serum concentration in climacteric women under various routes of hormone replacement therapy administration].
    Gadomska H; Grzechocińska B; Nowicka G; Marianowski L; Siemińska J
    Ginekol Pol; 2001 Dec; 72(12A):1398-404. PubMed ID: 11883286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
    Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
    Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.
    Cano A; Calaf J; Molina J
    Arch Gynecol Obstet; 2003 Oct; 268(4):317-22. PubMed ID: 14504877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J; Travica S; Metka M; Pietschmann P
    Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
    Mattsson LA; Cullberg G; Samsioe G
    Acta Obstet Gynecol Scand; 1984; 63(8):673-7. PubMed ID: 6524301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a compound containing isoflavones, primrose oil and vitamin E in two different doses on climacteric symptoms.
    Cancelo Hidalgo MJ; Castelo-Branco C; Blumel JE; Lanchares Pérez JL; Alvarez De Los Heros JI;
    J Obstet Gynaecol; 2006 May; 26(4):344-7. PubMed ID: 16753687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine administration of levonorgestrel in two low doses in HRT. A randomized clinical trial during one year: effects on lipid and lipoprotein metabolism.
    Wollter-Svensson LO; Stadberg E; Andersson K; Mattsson LA; Odlind V; Persson I
    Maturitas; 1995 Nov; 22(3):199-205. PubMed ID: 8746877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood lipids and the clinical state of hormone-treated women during menopause].
    Dominiczak-Gawrońska M
    Ann Acad Med Stetin; 1989; 35():145-66. PubMed ID: 2484147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of estradiol valerate and chlormadinone acetate in hormone replacement therapy in postmenopause on Kupperman index, body weight, blood pressure, lipids, enzymes and electrolytes].
    Göretzlehner G; Nikschick S; Zimmermann T
    Zentralbl Gynakol; 1996; 118(7):420-5. PubMed ID: 8766107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.